Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 3/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2728926 | 0.83 | CHRM1 (0.36) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Acetic Acid SCHEMBL1033681 | 0.82 | FFAR3 (0.39) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL82497 | 0.82 | TSHR (0.33) | — | |
| Butanone SCHEMBL27873964 | 0.80 | ALDH1A1 (0.53) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Bicarbonate SCHEMBL27506741 | 0.79 | FFAR3 (0.35) | CHRM1CHRM3 | |
| SCHEMBL9305389 | 0.79 | ALDH1A1 (0.32) | — | |
| SCHEMBL31602198 | 0.79 | ALDH1A1 (0.32) | — | |
| SCHEMBL30682108 | 0.79 | ALDH1A1 (0.32) | — | |
| Hydrochloric Acid SCHEMBL6491086 | 0.79 | ALDH1A1 (0.32) | — | |
| SCHEMBL28142086 | 0.77 | MEN1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060094877-A1 | Process for preparation of benzylpiperidine compounds | MIKI SHOKYO | 2006-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094877-A1 | Process for preparation of benzylpiperidine compounds | SBDS, DRD4, HRH1 | CHRM2 609/4885CHRM4 744/4885CHRM5 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.